BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 6188490)

  • 21. Reactions of thrombin with human factor VIII/von Willebrande factor protein.
    Switzer ME; McKee PA
    J Biol Chem; 1980 Nov; 255(22):10606-11. PubMed ID: 6776120
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Fukui H; Mikami S; Okuda T; Murashima N; Takase T
    Br J Haematol; 1977 Jun; 36(2):259-70. PubMed ID: 301402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human factor VIII and interaction with von Willebrand factor. An electron microscopic study.
    Heijnen HF; Koedam JA; Sandberg H; Beeser-Visser NH; Slot JW; Sixma JJ
    Eur J Biochem; 1990 Dec; 194(2):491-8. PubMed ID: 2125268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules].
    Furlan M; Perret BA; Beck EA
    Schweiz Med Wochenschr; 1980 Oct; 110(40):1456-8. PubMed ID: 6792697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF.
    Cockburn CG; de Beaufre-Apps RJ; Wilson J; Hardisty RM
    Thromb Res; 1981 Feb; 21(3):295-309. PubMed ID: 6454278
    [No Abstract]   [Full Text] [Related]  

  • 26. Reaction of alpha 2-macroglobulin with plasmin increases binding of transforming growth factors-beta 1 and beta 2.
    LaMarre J; Wollenberg GK; Gonias SL; Hayes MA
    Biochim Biophys Acta; 1991 Jan; 1091(2):197-204. PubMed ID: 1704799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of a novel serine proteinase complexed with alpha 2-macroglobulin from porcine gastric mucosa.
    Uchino T; Sakurai Y; Nishigai M; Takahashi T; Arakawa H; Ikai A; Takahashi K
    J Biol Chem; 1993 Jan; 268(1):527-33. PubMed ID: 7678002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factor VIII/von Willebrand factor in glomerular nephropathies.
    Coppola R; Guerra L; Ruggeri ZM; Tarantino A; Mannucci PM; Ponticelli C
    Clin Nephrol; 1981 Nov; 16(5):217-22. PubMed ID: 6796318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure.
    Harpel PC
    J Exp Med; 1973 Sep; 138(3):508-21. PubMed ID: 4269559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoassay of alpha 2-macroglobulin-enzyme complexes.
    Harpel PC
    Ann N Y Acad Sci; 1983; 421():134-42. PubMed ID: 6202186
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
    Layet S; Girma JP; Obert B; Peynaud-Debayle E; Bihoreau N; Meyer D
    Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW; Trabold NC
    J Lab Clin Med; 1981 Jan; 97(1):50-64. PubMed ID: 6778941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 34. Proteinase inhibitory spectrum of mouse murinoglobulin and alpha-macroglobulin.
    Abe K; Yamamoto K; Sinohara H
    J Biochem; 1989 Oct; 106(4):564-8. PubMed ID: 2481676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A monoclonal antibody to factor VIII inhibits von Willebrand factor binding and thrombin cleavage.
    Precup JW; Kline BC; Fass DN
    Blood; 1991 May; 77(9):1929-36. PubMed ID: 1902121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.
    Cooper HA; Reisner FF; Hall M; Wagner RH
    J Clin Invest; 1975 Sep; 56(3):751-60. PubMed ID: 1080490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of protease binding by alpha 2-macroglobulin on intrinsic fluorescence.
    Straight DL; McKee PA
    Biochemistry; 1982 Sep; 21(19):4550-6. PubMed ID: 6182901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
    Yada K; Nogami K; Shima M
    Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of individual tyrosine sulfation sites within factor VIII required for optimal activity and efficient thrombin cleavage.
    Michnick DA; Pittman DD; Wise RJ; Kaufman RJ
    J Biol Chem; 1994 Aug; 269(31):20095-102. PubMed ID: 8051097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.